Synergistic effects of bee venom, hesperidin, and piperine with tamoxifen on apoptotic and angiogenesis biomarker molecules against xerographic MCF-7 injected rats.

Breast cancer ranks as the second leading most significant of mortality for women. Studies have demonstrated the potential benefits of natural compounds in cancer treatment and prevention, either in isolation or in conjunction with chemotherapy. In order to improve Tamoxifen's therapeutic efficacy in in-vivo studies, our research sought to determine the effects of hesperidin, piperine, and bee venom as natural compounds, as well as their combination effect with or without Tamoxifen. First, 132 female albino rats were equally divided into six groups and five subgroups, and breast cancer was induced in the selected groups by xenografting of MCF7 cells. Second, the effect of single and best ratio combinations treatment from previous in vitro studies were selected. Next, tumorous mammary glands were collected for apoptotic and antiapoptotic biomarkers and cell cycle analysis. Single or combined natural products with or without Tamoxifen revealed a significant up-regulation in apoptotic genes Bax and Casp3 and a downregulation of antiapoptotic and angiogenesis genes Bcl-2 and VEGF genes. We found that cell cycle arrest in the G0/G1 phase was exclusively caused by Tamoxifen and/ or hesperidin. However, the cell cycle arrest in the G2/M phase is a result of the combination of piperine and bee venom, with or without Tamoxifen by using the flow cytometric technique. Our research concludes that bee venom, hesperidin, and piperine can synergistically enhance to increase Tamoxifen's efficiency in the management of breast cancer.

Sulfonation of Natural Carbonaceous Bentonite as a Low-Cost Acidic Catalyst for Effective Transesterification of Used Sunflower Oil into Diesel; Statistical Modeling and Kinetic Properties.

Bentonite sample enriched in organic matters (oil shale) was functionalized with -SO3H sulfonated carbonaceous bentonite (S-CB) by sulfonation process as a low-cost and effective acidic catalyst for the transesterification spent sunflower oil (SFO). The sulfonation effect was followed by several analytic techniques including X-ray diffraction, Fourier transform infrared, and scanning electron microscopy analysis. The catalytic performance of the sulfonated product was evaluated based on a statistical design which was built according to the response surface methodology and the central composite rotatable design. Using the S-CB acidic catalyst in the transesterification of spent SFO resulted in an actual biodiesel yield of 96% at studied conditions of 85 min at reaction interval, 50 °C as temperature,15:1 as methanol/oil ratio, and 3.5 wt % as S-CB loading. Moreover, the optimization function suggested enhancement to obtained yield up to 97.9% by selecting the values of temperature at 62 °C, the time at 98.5 min, the methanol/SFO ratio at 14.4:1, and S-CB loading at 3.4 wt %. The technical evaluation of the SFO biodiesel reflected the suitability of the product to be used as biofuels according to international standards. The kinetic behavior of the SFO transesterification reaction over S-CB is of pseudo-first order properties and of low activation energy. Finally, the synthetic S-CB as a solid acidic catalyst is of significant reusability and was reused five times with remarkable biodiesel yields.

Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.

Despite advances in cancer treatment, breast cancer remains one of the main life threatening diseases in women. Most anti-breast cancer drugs cause severe health complications and multidrug resistance. Although, some natural products, such as hesperidin (Hes), piperine (Pip) and bee venom (BV), showed anti-breast cancer effect when used separately, their combined effect together or with the anti-cancer drug tamoxifen (Tam) has not yet been studied. Herein, we hypothesized that these three natural products could potentiate the therapeutic effect of Tam when used together. First, we studied the cytotoxic effect of Hes, Pip, and BV on MCF7 and T47D cells using MTT assay and found reasonable IC50 comparable to that of Tam. Second, we checked the effect of all combinations (n = 67 for each cell line, prepared as non-constant ratio from fractions of IC50 of the four compounds) and found enhanced anti-proliferative effects on MCF7 and T47D and synergistic effect, revealed by combination index (CI) values below one. Next, the best 5 combinations with lowest Tam doses and CI but with highest cell death were selected for further molecular analysis in comparison to single-drug treatment. All single- and combined-treated groups showed a significant increase in apoptosis (indicated by upregulated mRNA level of the pro-apoptotic marker Bax and downregulated mRNA level of the anti-apoptotic marker Bcl2) and a significant decrease in mRNA level of the two breast cancer related receptors EGFR and ERα, with the best effect in combined groups especially that contained the 4 compounds, as compared to vehicle-treated group. Moreover, Pip, BV and all combinations, except Tam + Hes group, arrested MCF7 and T47D in G2/M phase of cell cycle, while Tam and/or Hes caused G0/G1 phase arrest. These results indicate that Hes, Pip and BV synergistically enhance the anti-cancer effect of Tam and could be used as safe adjuvant/vehicle to Tam in treatment of breast cancer after further confirmatory in vivo investigations.